What is the address of DOKTER LIEVEN HERBOTS, CARDIOLOOG?

The registered office of DOKTER LIEVEN HERBOTS, CARDIOLOOG is located at Kerkebos 6, 3221 Holsbeek.

Is DOKTER LIEVEN HERBOTS, CARDIOLOOG still active?

Yes. According to the CBE (29 September 2026) DOKTER LIEVEN HERBOTS, CARDIOLOOG is active, legal situation “Normale toestand”, started on 26 April 2012.

Is DOKTER LIEVEN HERBOTS, CARDIOLOOG registered on Peppol?

Yes, DOKTER LIEVEN HERBOTS, CARDIOLOOG is registered on the Peppol network with ID 0208:0845810504.

What is the enterprise number of DOKTER LIEVEN HERBOTS, CARDIOLOOG?

The enterprise number of DOKTER LIEVEN HERBOTS, CARDIOLOOG is BE0845810504.

When was DOKTER LIEVEN HERBOTS, CARDIOLOOG founded?

DOKTER LIEVEN HERBOTS, CARDIOLOOG was founded on 26 April 2012.

Who are the directors of DOKTER LIEVEN HERBOTS, CARDIOLOOG?

According to the 2024 annual accounts, the directors of DOKTER LIEVEN HERBOTS, CARDIOLOOG are: LIEVEN HERBOTS.

Is DOKTER LIEVEN HERBOTS, CARDIOLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 April 2012; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did DOKTER LIEVEN HERBOTS, CARDIOLOOG make in 2024?

DOKTER LIEVEN HERBOTS, CARDIOLOOG posted a profit after taxes of € 358,599 in financial year 2024.

What is the revenue of DOKTER LIEVEN HERBOTS, CARDIOLOOG?

As a small company, DOKTER LIEVEN HERBOTS, CARDIOLOOG is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 467,820.

DOKTER LIEVEN HERBOTS, CARDIOLOOG (Private Limited)

Dossier DOKTER LIEVEN HERBOTS, CARDIOLOOG, printed on 29 September 2026 from databakkes.be/en/0845810504/dokter-lieven-herbots-cardioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Late annual account NBB

Fiscal year 2024 was filed 265 days after the legal deadline.

Financials

Financial year 2024

DOKTER LIEVEN HERBOTS, CARDIOLOOG from Holsbeek, company number BE0845810504, closed financial year 2024 with a result of € 358,599 after tax. For that financial year DOKTER LIEVEN HERBOTS, CARDIOLOOG recorded a gross margin of € 467,820 and equity of € 1.6 million. Compared with financial year 2023, the result moved from € 315,503 to € 358,599. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 22, 2026.

What it is worth Growing

€ 1.6 million

▲ 30% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 358,599

▲ 14% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 47,691

▲ 8% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 1.5 million.

Debts at end 2024

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 31,514

▼ 47% vs 2023

€ 28,069 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 7,751

▲ 11% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 145,149

▲ 103% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 392,588 Gross margin 2021: € 392,588 First fiscal year in the series	€ 349,529 Gross margin 2022: € 349,529 ▼ 11% vs 2021 (€ 392,588) Unfavourable step	€ 412,936 Gross margin 2023: € 412,936 ▲ 18% vs 2022 (€ 349,529) Favourable step	€ 467,820 Gross margin 2024: € 467,820 ▲ 13% vs 2023 (€ 412,936) Favourable step	▲ 13%
Profit after taxes	€ 225,717 Profit after taxes 2021: € 225,717 First fiscal year in the series	€ 247,944 Profit after taxes 2022: € 247,944 ▲ 10% vs 2021 (€ 225,717) Favourable step	€ 315,503 Profit after taxes 2023: € 315,503 ▲ 27% vs 2022 (€ 247,944) Favourable step	€ 358,599 Profit after taxes 2024: € 358,599 ▲ 14% vs 2023 (€ 315,503) Favourable step	▲ 14%
Equity	€ 1,064,824 Equity 2021: € 1,064,824 First fiscal year in the series	€ 1,312,768 Equity 2022: € 1,312,768 ▲ 23% vs 2021 (€ 1,064,824) Favourable step	€ 1,200,348 Equity 2023: € 1,200,348 ▼ 9% vs 2022 (€ 1,312,768) Unfavourable step	€ 1,558,946 Equity 2024: € 1,558,946 ▲ 30% vs 2023 (€ 1,200,348) Favourable step	▲ 30%
Total debts	€ 215,667 Total debts 2021: € 215,667 First fiscal year in the series	€ 123,591 Total debts 2022: € 123,591 ▼ 43% vs 2021 (€ 215,667) Favourable step	€ 319,880 Total debts 2023: € 319,880 ▲ 159% vs 2022 (€ 123,591) Unfavourable step	€ 357,709 Total debts 2024: € 357,709 ▲ 12% vs 2023 (€ 319,880) Unfavourable step	▲ 12%
Cash	€ 49,121 Cash 2021: € 49,121 First fiscal year in the series	€ 46,712 Cash 2022: € 46,712 ▼ 5% vs 2021 (€ 49,121) Unfavourable step	€ 44,262 Cash 2023: € 44,262 ▼ 5% vs 2022 (€ 46,712) Unfavourable step	€ 47,691 Cash 2024: € 47,691 ▲ 8% vs 2023 (€ 44,262) Favourable step	▲ 8%
Retained profit	€ 1,052,424 Retained profit 2021: € 1,052,424 First fiscal year in the series	€ 1,300,368 Retained profit 2022: € 1,300,368 ▲ 24% vs 2021 (€ 1,052,424) Favourable step	€ 1,187,948 Retained profit 2023: € 1,187,948 ▼ 9% vs 2022 (€ 1,300,368) Unfavourable step	€ 1,546,546 Retained profit 2024: € 1,546,546 ▲ 30% vs 2023 (€ 1,187,948) Favourable step	▲ 30%
Dividend	€ 323,504 Dividend 2021: € 323,504 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 323,504) Unchanged	€ 427,924 Dividend 2023: € 427,924 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 427,924) Unchanged	▼ 100%
Bank debt	€ 47,403 Bank debt 2021: € 47,403 First fiscal year in the series	€ 8,784 Bank debt 2022: € 8,784 ▼ 81% vs 2021 (€ 47,403) Favourable step	€ 59,064 Bank debt 2023: € 59,064 ▲ € 50,280 vs 2022 (€ 8,784) Unfavourable step	€ 31,514 Bank debt 2024: € 31,514 ▼ 47% vs 2023 (€ 59,064) Favourable step	▼ 47%
Balance sheet total	€ 1,280,491 Balance sheet total 2021: € 1,280,491 First fiscal year in the series	€ 1,436,359 Balance sheet total 2022: € 1,436,359 ▲ 12% vs 2021 (€ 1,280,491) Unchanged	€ 1,520,228 Balance sheet total 2023: € 1,520,228 ▲ 6% vs 2022 (€ 1,436,359) Unchanged	€ 1,916,655 Balance sheet total 2024: € 1,916,655 ▲ 26% vs 2023 (€ 1,520,228) Unchanged	▲ 26%

Key figures of DOKTER LIEVEN HERBOTS, CARDIOLOOG, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to DOKTER LIEVEN HERBOTS, CARDIOLOOG?

What happened at DOKTER LIEVEN HERBOTS, CARDIOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 22, 2026 New annual accounts for financial year 2024: profit of € 358,599 (▲ 14% vs 2023). filed late Source: NBB ↗
Apr 26, 2012 New establishment in Holsbeek. KBO
Apr 26, 2012 Start of the company according to the CBE. KBO

In short

From € 225,717 profit in 2021 to € 358,599 profit in 2024.

Paid € 519,188 in corporate taxes since 2021.

Best year ever: 2024, with € 358,599 profit.

Paid out € 751,428 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER LIEVEN HERBOTS, CARDIOLOOG? We notify you, reason included.

Follow DOKTER LIEVEN HERBOTS, CARDIOLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

LIEVEN HERBOTS

DOKTER LIEVEN HERBOTS, CARDIOLOOG

Behind DOKTER LIEVEN HERBOTS, CARDIOLOOG is LIEVEN HERBOTS.

See the full network in the app

Directors

According to the 2024 annual accounts

LIEVEN HERBOTS

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkebos 6

3221 Holsbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0845.810.504
VAT number: BE 0845.810.504
Registered office: Kerkebos 6, 3221 Holsbeek
Names & denominations: DOKTER LIEVEN HERBOTS, CARDIOLOOG
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 April 2012
Peppol: Active · Active since 9 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗